News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
291,892 Results
Type
Article (14238)
Company Profile (104)
Press Release (277550)
Section
Business (97171)
Career Advice (467)
Deals (17412)
Drug Delivery (60)
Drug Development (39781)
Employer Resources (49)
FDA (7015)
Job Trends (6539)
News (165686)
Policy (15437)
Tag
Academia (495)
Africa (336)
Alliances (26447)
Alzheimer's disease (373)
Approvals (6997)
Arizona (36)
Artificial intelligence (39)
Asia (30236)
Australia (3911)
Bankruptcy (145)
Best Places to Work (4482)
Biosimilars (32)
Biotechnology (42)
C2C Services and Suppliers (15915)
California (637)
Canada (480)
Cancer (159)
Career advice (409)
Cell therapy (25)
China (82)
Clinical research (32659)
Collaboration (55)
Compensation (24)
Connecticut (25)
COVID-19 (835)
Cystic fibrosis (22)
Data (104)
Diabetes (31)
Diagnostics (1652)
Drug pricing (47)
Earnings (34665)
Employer resources (43)
Europe (44407)
Events (40038)
Executive appointments (82)
FDA (7094)
Florida (75)
Funding (41)
Gene therapy (41)
GLP-1 (265)
Government (1374)
Healthcare (4118)
Hotbed/Location (191641)
Illinois (71)
Indiana (59)
Infectious disease (839)
Inflammatory bowel disease (45)
Interviews (57)
IPO (6632)
Job creations (2125)
Job search strategy (378)
Kansas (53)
Layoffs (166)
Legal (3748)
Liver cancer (26)
Lung cancer (34)
Manufacturing (45)
Maryland (124)
Massachusetts (560)
Medical device (2196)
Medtech (2199)
Mergers & acquisitions (10720)
Metabolic disorders (107)
Minnesota (54)
Neuroscience (430)
New Jersey (259)
New York (195)
NextGen Class of 2024 (1686)
Non-profit (626)
North Carolina (242)
Northern California (292)
Obesity (61)
Ohio (29)
Opinion (107)
Patents (40)
Pennsylvania (196)
People (30081)
Pharmaceutical (59)
Phase I (8673)
Phase II (13901)
Phase III (12191)
Pipeline (55)
Podcasts (35)
Policy (36)
Postmarket research (1444)
Preclinical (3472)
Press Release (27)
Rare diseases (53)
Real estate (2893)
Regulatory (10693)
Research institute (598)
Resumes & cover letters (55)
South America (547)
Southern California (278)
Startups (1842)
Texas (77)
United States (2855)
Vaccines (96)
Washington State (46)
Weight loss (52)
Date
Today (19)
Last 7 days (245)
Last 30 days (790)
Last 365 days (15022)
2024 (10418)
2023 (16098)
2022 (22799)
2021 (23374)
2020 (21938)
2019 (16683)
2018 (13050)
2017 (15470)
2016 (14651)
2015 (17260)
2014 (13929)
2013 (11943)
2012 (12847)
2011 (13344)
2010 (12125)
291,892 Results for "salix pharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today announced that they will be presenting data from its Phase 2 trial evaluating Amiselimod as treatment for active ulcerative colitis (UC).
May 17, 2024
·
4 min read
Business
Salix Announces 2024 Gastrointestinal Health Scholars Program
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the opening of the 2024 Salix Gastrointestinal Health Scholars Program application period.
February 12, 2024
·
3 min read
Business
Salix Pharmaceuticals Partners with Bellamy Young
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business, Salix Pharmaceuticals, today announced its partnership with award-winning actor Bellamy Young, who is speaking out to help educate people who are impacted by hepatic encephalopathy (HE), caused by cirrhosis.
October 4, 2023
·
5 min read
Business
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
Bausch Health Companies Inc. today announced award-winning actor, Bellamy Young, as the brand ambassador in a new campaign to raise awareness of Xifaxan, the first and only FDA approved medication to reduce the risk of overt hepatic encephalopathy (OHE) recurrence in adults.
May 9, 2024
·
6 min read
BioCapital
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
Vanda Pharmaceuticals Inc. confirmed that it has received an unsolicited, non-binding indication of interest from Cycle Group Holdings Ltd. to acquire the Company for $8.00 per share in cash.
June 6, 2024
·
3 min read
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
Salix Pharmaceuticals today released the Salix Liver Health Trends Report, Third Edition, which documents the evolving crisis of chronic liver disease (CLD), showing a 9% increase in CLD and cirrhosis mortality marking these as the ninth leading cause of death in the United States in 2021.
October 10, 2023
·
5 min read
Business
Salix Announces 2023 Gastrointestinal Health Scholars Program Winners
Bausch Health Companies Inc. (NYSE/TSX:BHC) and its gastroenterology business, Salix Pharmaceuticals, today announced the winners of its 2023 Salix Gastrointestinal Health Scholars Program.
July 11, 2023
·
4 min read
Pharm Country
Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day
Salix Pharmaceuticals, the gastroenterology division of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), The U.S. Pain Foundation (USPF), and The International Foundation for Gastrointestinal Disorders (IFFGD) today announced they are joining forces to declare Tuesday, Dec. 5, Opioid-Induced Constipation (OIC) Awareness Day.
December 5, 2023
·
4 min read
Business
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
Verrica Pharmaceuticals Inc. today announced that it has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. (Torii), to jointly conduct a global pivotal Phase 3 clinical trial of YCANTH® for the treatment of common warts.
May 15, 2024
·
9 min read
Business
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023
Galmed Pharmaceuticals Ltd. announced that it has filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission.
April 4, 2024
·
5 min read
1 of 29,190
Next
